RDHL today
$0.37-$0.01 (-2.43%)close Nov 11, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourSymmetric Triangle
15 minBearish
5 minConsolidating
Daily trend turns up above $0.69
Key levels
Resistance$0.47
Resistance$0.39
Latest news & SEC filings
ProductRedhill Biopharma confirms RHB-204 kills MAP bacteria, comparable to RHB-104
NewsCongo Ebola Outbreak Surpasses 10,000 Cases
All RDHL news →About RedHill Biopharma
RedHill Biopharma is a drugmaker focused on gastrointestinal, infectious, and cancer therapies, based in Israel with its main commercial base in North Carolina. Its approved medicine Talicia is used against Helicobacter pylori in adults and is sold in the United States with Cumberland and in parts of the Middle East. The company's development pipeline covers several experimental treatments, including opaganib, upamostat, and candidates for Crohn's disease, acute gastroenteritis, and irritable bowel syndrome.
Based on the company's 20-F filed Apr 27, 2026.
Nasdaq · Healthcare
RedHill Biopharma Ltd. (RDHL)
What Is the Price Target for RDHL?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is RDHL a Buy or Sell Right Now?
Thesis
- •Revenue growing 23.2% YoY with ACCELERATING trend — accelerating momentum.
- •SEC filings signal active product innovation — 1 new product/expansion keywords detected in 10-K. R&D investment stable.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for RDHL.
Start Free Trial →Is RDHL Overvalued or Undervalued?
Valuation Verdict
N/A
Methods Used
N/A
Fair Value
$N/A
62
Moat Score
NARROW
2/9
Piotroski Score
-35.1
Altman Z-Score
What Is Smart Money Doing with RDHL?
Insider Signal
NEUTRAL
0 buys / 1 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Raday Gilead | officer | Sale | 14,310,000 | $1K | Oct 1, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →RDHL Growth Story
Revenue YoY
23.2%
3yr Revenue CAGR
-54.6%
EPS Growth YoY
-115.22%
FCF Growth YoY
73.8%
Revenue Trend
ACCELERATING
Dark Pool Trades for RDHL
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for RDHL, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:10:04 | $0.38 | 1,000 | $$378 | BUY |
| 14:43:17 | $0.38 | 3,000 | $$1K | SELL |
| 14:42:06 | $0.39 | 3,000 | $$1K | SELL |
| 14:31:51 | $0.38 | 2,000 | $$750 | SELL |
| 19:10:47 | $0.38 | 2,500 | $$938 | MIDPOINT |
5 dark pool trades shown · $$4K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for RedHill Biopharma Ltd. (RDHL) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →RDHL — frequently asked questions
What is RDHL stock price today?
RedHill Biopharma Ltd. (RDHL) is at $0.37, down 2.43% (-$0.01) at the Nov 11, 2026 close.
Why is RDHL stock moving today?
Latest RDHL news — Nov 2, 2026: Redhill Biopharma confirms RHB-204 kills MAP bacteria, comparable to RHB-104 · Oct 27, 2026: Congo Ebola Outbreak Surpasses 10,000 Cases
Does RDHL pay a dividend?
RDHL does not currently pay a dividend.
How much debt does RDHL have?
RedHill Biopharma Ltd. reported $0M of debt and $5M of cash (Dec 31, 2024).
What are RDHL support and resistance levels?
Resistance: $0.39, $0.47, $0.52.
What are insiders doing with RDHL?
Insider activity: NEUTRAL, 0 buys and 1 sells in the last 90 days.
What is the latest news on RDHL?
Nov 2, 2026: Redhill Biopharma confirms RHB-204 kills MAP bacteria, comparable to RHB-104 · Oct 27, 2026: Congo Ebola Outbreak Surpasses 10,000 Cases